isosorbide dinitrate has been researched along with ranolazine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bueno, O; Zavecz, JH | 1 |
| Dunlap, ME; Ibrahim, OA | 1 |
| Belardinelli, L; Hintze, TH; Messina, E; Ochoa, M; Serpillon, S; Shryock, J; Xu, X; Zhao, G | 1 |
| Dixit, D; Kimborowicz, K | 1 |
| Crea, F; De Vita, A; Di Franco, A; Golino, M; Lamendola, P; Lanza, GA; Manfredonia, L; Melita, V; Mencarelli, E; Spera, FR; Villano, A | 1 |
| Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
4 review(s) available for isosorbide dinitrate and ranolazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents | 1995 |
Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?
Topics: Acetanilides; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Piperazines; Pyridines; Ranolazine; Tetrazoles; Tolvaptan; Vasodilator Agents | 2005 |
Pharmacologic management of chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents | 2015 |
2 trial(s) available for isosorbide dinitrate and ranolazine
| Article | Year |
|---|---|
Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate.
Topics: Aged; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Cross-Over Studies; Female; Humans; Isosorbide Dinitrate; Male; Microcirculation; Microvessels; Middle Aged; Percutaneous Coronary Intervention; Ranolazine; Rome; Single-Blind Method; Time Factors; Treatment Outcome; Vasodilator Agents | 2018 |
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
1 other study(ies) available for isosorbide dinitrate and ranolazine
| Article | Year |
|---|---|
Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Topics: Acetanilides; Angina Pectoris; Animals; Blood Pressure; Dogs; Enzyme Inhibitors; Heart Rate; Hypotension; Injections, Intravenous; Isosorbide Dinitrate; Male; Piperazines; Purines; Ranolazine; Sildenafil Citrate; Stimulation, Chemical; Sulfones; Vasodilator Agents | 2006 |